言語を選択

CD81

CD81 製品リスト

属性
Protein (2)
製品ライブラリ
オンライン (2)
種
Human (2)
タグ
His Tag & Avi Tag & Flag Tag (1)- (1)
マーカー
Biotin-labeled (1)Unconjugated (1)

製品番号	種	発現システム	製品説明	タンパク質の構造	純度	特性
CD1-H52P5	Human	HEK293	Human CD81 Full Length Protein (VLP)
CD1-H85D8	Human	InsectCells	Biotinylated Human CD81 Protein, His,Avitag™&Flag Tag (Detergent)

総数量2

CD81バックグランド

The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins. This protein appears to promote muscle cell fusion and support myotube maintenance. Also it may be involved in signal transduction. This gene is localized in the tumor-suppressor gene region and thus it is a candidate gene for malignancies. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]

治験薬に関する情報

英語名	研究コード	研究開発ステージ	会社	適応症	臨床試験
IBC-0966	IBC-0966	Phase 2 Clinical	SunHo (China) BioPharmaceutical Co Ltd	Neoplasms	詳細
BI-765063	OSE-172; BI-765063	Phase 1 Clinical	Ose Immunotherapeutics	Solid tumours; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Melanoma; Carcinoma, Non-Small-Cell Lung	詳細
Anzurstobart	BMS-986351; CC-95251	Phase 1 Clinical	Celgene Corp	Myelodysplastic Syndromes; Leukemia, Myeloid, Acute	詳細
ADU-1805	ADU-1805	Phase 1 Clinical	Aduro Biotech Inc	Solid tumours; Neoplasms; Neoplasm Metastasis	詳細
LM-101	LM-101	Phase 1 Clinical	LaNova Medicines Ltd	Leukemia; Solid tumours; Hematologic Neoplasms; Neoplasms	詳細
Q-1801	Q-1801; Q 1801	Phase 1 Clinical	Qiyu Biotechnology (Shanghai) Co Ltd	Solid tumours	詳細
Recombinant humanized IgG4 anti-SIRPα antibody（Daiichi Sankyo）	DS-1103a	Phase 1 Clinical	Daiichi Sankyo Co Ltd	Solid tumours; Breast Neoplasms	詳細
ELA-026	ELA-026	Phase 1 Clinical	Electra Therapeutics Inc	Lymphohistiocytosis, Hemophagocytic	詳細
BYON-4228	BYON-4228	Phase 1 Clinical	Byondis Bv	Solid tumours; Lymphoma	詳細
BSI-082	BSI-082	Phase 1 Clinical	Boaoxin Biotechnology(Nanjing) Co Ltd	Hematologic Neoplasms; Solid tumours	詳細
BR-105	BR-105; BR105	Phase 1 Clinical	BioRay Pharmaceutical Co Ltd	Neoplasms; Lymphoma, Large B-Cell, Diffuse	詳細
[89Zr]Zr- BI-765063(Boehringer Ingelheim)		Phase 1 Clinical	Boehringer Ingelheim Corp	Squamous Cell Carcinoma of Head and Neck; Carcinoma, Non-Small-Cell Lung; Melanoma	詳細
TQB-2928	TQB-2928	Phase 1 Clinical		Hematologic Neoplasms; Solid tumours; Myelodysplastic Syndromes; Neoplasms; Leukemia, Myeloid, Acute	詳細
BI-765080		Phase 1 Clinical	C.H. Boehringer Sohn Ag & Co. Kg		詳細
ES-004	ES-004; ES 004-N4; ES 004-B4	Phase 1 Clinical		Solid tumours; Neoplasms	詳細

市販薬剤に関する情報

英語名	研究コード	研究開発ステージ	会社	オリジナル製品名	最初に承認をした国	最初の適応症	最初に承認を受けた会社	承認された日付	適応症	臨床試験
Relugolix/Estradiol/Norethindrone Acetate	E2/NETA	Approved	Myovant Sciences	MYFEMBREE, RYEQO	United States	Menorrhagia; Leiomyoma	Myovant Sciences	2021-05-26	Pain; Endometriosis; Leiomyoma; Menorrhagia; Uterine Neoplasms	詳細
Elagolix/estradiol/norethindrone acetate		Approved	Abbvie Inc	Oriahnn	United States	Menorrhagia	Abbvie Inc	2020-05-29	Menorrhagia	詳細